tradingkey.logo

Fortrea Holdings Inc

FTRE
9.668USD
0.0000.00%
Close 11/03, 16:00ETQuotes delayed by 15 min
877.85MMarket Cap
LossP/E TTM

Fortrea Holdings Inc

9.668
0.0000.00%

More Details of Fortrea Holdings Inc Company

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc Info

Ticker SymbolFTRE
Company nameFortrea Holdings Inc
IPO dateJun 16, 2023
CEOMr. Anshul Thakrala
Number of employees15500
Security typeOrdinary Share
Fiscal year-endJun 16
Address8 Moore Drive
CityDURHAM
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code27709
Phone18774950816
Websitehttps://www.fortrea.com/
Ticker SymbolFTRE
IPO dateJun 16, 2023
CEOMr. Anshul Thakrala

Company Executives of Fortrea Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Other
55.93%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Other
55.93%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.71%
Hedge Fund
24.43%
Investment Advisor/Hedge Fund
22.87%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.34%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
948
101.58M
111.87%
-11.06M
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Starboard Value LP
2.50M
2.75%
-220.86K
-8.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.17M
2.39%
+589.14K
+37.23%
Jun 30, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
Brandes US Small-Mid Cap Value ETF
1.13%
Invesco S&P Spin-Off ETF
0.83%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco S&P SmallCap 600 Pure Value ETF
0.19%
Invesco S&P SmallCap 600 Revenue ETF
0.17%
Schwab Fundamental U.S. Small Company ETF
0.14%
Humankind US Stock ETF
0.12%
SPDR S&P 600 Small Cap Value ETF
0.11%
iShares S&P Small-Cap 600 Value ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.08%
View more
Brandes US Small-Mid Cap Value ETF
Proportion1.13%
Invesco S&P Spin-Off ETF
Proportion0.83%
Invesco S&P SmallCap Health Care ETF
Proportion0.49%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.19%
Invesco S&P SmallCap 600 Revenue ETF
Proportion0.17%
Schwab Fundamental U.S. Small Company ETF
Proportion0.14%
Humankind US Stock ETF
Proportion0.12%
SPDR S&P 600 Small Cap Value ETF
Proportion0.11%
iShares S&P Small-Cap 600 Value ETF
Proportion0.11%
ProShares Ultra Nasdaq Biotechnology
Proportion0.08%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI